Skip to content
Catalyst

PapersPMID:30895694

The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial.

Phytotherapy research2019The record ↗

findings
3
compound
1
endpoints
3
PMID:30895694
  1. Finding, very limited evidencelowersFasting blood glucose
  2. Finding, very limited evidencelowersTotal cholesterol (TC)
  3. Finding, very limited evidencelowersLDL cholesterol
Study, every finding
RCT · 8 weeks
Dose studied, every finding
10 g/day purslane seeds sachet, before breakfast and dinner, for 8 weeks
Population, every finding
adults with nonalcoholic fatty liver disease, low-calorie diet in both arms
  • “Intake of purslane seeds with the low-calorie diet led to a significant decrease in serum concentrations of fasting blood sugar (FBS; -3.52 ± 10.45 compared with 3.03 ± 9.01 mg/dl, P = 0.017), quantitative insulin sensitivity check index (QUICKI; 0.13 ± 0.27 compared with -0.002 ± 0.016, P = 0.017), total cholesterol (4.33 ± 34.04 compared with 23.48 ± 29.47 mg/dl, P = 0.032), and low-density lipoprotein cholesterol (LDL-C; -4.35 ± 22.65 compared with 11.82 ± 16.08 mg/dl, P = 0.004) after intervention.”

Study record

Design
randomised controlled trial
Species
human
Population
Individuals with NAFLD; whole purslane (Portulaca oleracea) seeds 10 g/day plus low-calorie diet vs low-calorie diet alone; open control (no placebo); abstract only
Participants
54
Comparator
no treatment
Duration
56 days
Endpoints measured
8